from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1354c/-

LFCtreatmentdescriptionclass of inhibitor

0.398

Amikacinug/mL Amikacintranslation

-0.311

Cap5-10ug/mL Capreomycintranslation

-0.273

Rox10-50 ug/mL Roxithromycintranslation

-0.001

SM2-5 ug/mL Streptomycintranslation

0.037

Tet5-10 ug/mL Tetracyclinetranslation

0.039

Rif0.2-5ug/mL Rifampicintranscription

0.310

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.546

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.981

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.391

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.152

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.332

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.111

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.276

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.169

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.941

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.471

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.493

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.863

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.263

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.362

Nigericin50 uM Nigericinrespiration

0.207

TRC10-150 ug/mL Triclosanrespiration

0.382

TRZ10-25 ug/mL Thioridazinerespiration

-0.363

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.545

menadione6-10 ug/mL Menadionerespiration

0.581

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.040

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.488

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.345

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.734

NRP_1Non-replicating persistence stage 1dosRassociated

0.539

Amp0.2mg/mL AmpicillincellWall

-0.292

Cephalexin20-100 ug/mL CephalexincellWall

0.770

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.035

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.097

EMB10-20 ug/mL EthambutolcellWall

-0.136

Eta12-40 ug/mL EthionamidecellWall

-0.913

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.770

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.657

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.388

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.276

BZA0.12 mg/mL BenzamidearomaticAmides

0.197

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.165

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.417

H2O24 mM hydrogen peroxideDNAdamaging

0.280

Levo10 ug/mL LevofloxacinDNAdamaging

-0.660

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.158

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.350

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.478

UVUV-irradiationDNAdamaging

-0.032

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.340

Antimycin12.5-50 ug/mL Antimycin A?

-0.445

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.429

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.164

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.370

PA8240.2-2 ug/mL PA-824?

-0.164

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.211

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.483

Verapamil50 uM Verapamil?

-0.188

mercaptoethanol2 mM 2-Mercaptoethanol?

0.373

methoxatin10-20 ug/mL Methoxatin?